International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-01-11-2021-1032
Total View : 436

Abstract : Upper aerodigestive tract (UADT) cancers is the common cancer in the world and the seventh most common cause of death from cancer worldwide. Some studies showed that Human Papillomavirus (HPV), Epstein-Barr virus (EBV) and Helicobacter pylori (H. pylori) infection is related to upper aerodigestive tract cancers. The aim of the study is to estimate the premature mortality cost related to infection of HPV, EBV, and H. Pylori in ASEAN. This research was a descriptive study using UADT cancers incidence and mortality data extracted from GLOBOCAN 2020. Population attributable fraction of six UADT cancers were calculated by reviewing previous studies of the infection prevalence data of 10 countries in ASEAN and relative risks of UADT cancers along with the mortality data from GLOBOCAN 2020. The burden of cancers attributable to HPV, EBV and H. Pylori Infection in ASEAN were calculated in term of premature mortality cost. Premature mortality cost was calculated by multiplying HPV, EBV and H. Pylori infection-related cancer mortality, ASEAN life expectancy, and ASEAN average income. According to the PAF estimation, HPV is responsible for approximately 5% - 18% of UADT cancer, whereas EBV is responsible for approximately 15% - 91% of UADT cancer. Helicobacter Pylori HPV is responsible for between 16 and 69% of UADT cancer in ASEAN. The highest PMC for males is $516 million due to nasopharynx cancer caused by EBV infection in Indonesia, and the highest PMC for females is $300 million due to nasopharynx cancer caused by EBV infection in Indonesia. In ASEAN, nasopharyngeal cancer has the largest cost of premature mortality due to HPV, EBV, and H. Pylori. In terms of excess deaths, it imposes a significant economic burden. The burden of UADT can be reduced by intervention in lifestyle, education in health care and policies..
Full article
International Medical Journal
Journal ID : IMJ-01-11-2021-1031
Total View : 441

Abstract : Cancer is one of the leading causes of death in the world, oral chemotherapy is an increasingly important treatment option for cancer This study aims to determine the level of adherence to capecitabine and its contributing factors such as sociodemographic characteristics, side effect, and QALY (quality of life) among cancer outpatients. This study was cross sectional study conducted from March to May 2021 at a referral hospital in Yogyakarta. The participant was outpatients with capecitabine treatment, with colorectal or breast cancer in all stages, with a total of 135 patients. This study using the Medication Adherence Rating Scale (MARS) for measuring adherence and the EQ5D-5L dimension for measuring the quality of life. Data collected was analyzed by using SPSS. Correlation between adherence and characteristics of patient analyzed with bivariate analysis using the chi-square test. Patient adherence with capecitabine was 64.44%. There are some factors that are significant associated with adherence of patients like comorbidities, stage of cancer, the regiment of capecitabine, use of traditional medicine, experienced symptom, and quality of life. Meanwhile type of cancer did not have correlation with adherence of patient (p<0.05). Although no absolute adherence to oral capecitabine treatment had been observed, the level of adherence was fair. Health professionals, therefore, need a greater focus in monitoring the involvement of patients with oral treatment regimens. The results underline the importance of intensified multidisciplinary care to enhance adherence to capecitabine..
Full article
International Medical Journal
Journal ID : IMJ-30-10-2021-1030
Total View : 331

Abstract : Rickettsial diseases are vector borne diseases commonly affecting the travellers to endemic areas. Various systemic involvement has been reported. The incidence of central nervous system involvement has been increasingly reported due to the globalization and migrations. However, its diagnosis is becoming challenging due to its nonspecific presentation. Various types of rickettsial infections are prevalent in India. However, incidence of Rocky Mountain spotted fever is rare. Here we present a case of RMSF infection with CNS and ocular involvement..
Full article
International Medical Journal
Journal ID : IMJ-30-10-2021-1029
Total View : 346

Abstract : Amitraz is acaricide and insecticide for cattle. Poisoning with Amitraz is often confused as organophosphorus (OP) poisoning or carbamates poisoning as Amitraz poisoning has a several clinical features that mimics OP poisoning. Signs like bradycardia, constricted pupils, hyperglycemia, increased respiratory rate are common. A 17 years old female, brought to ER with alleged history of (h/o) con- sumption of Amitraz in an unconscious state i.e.Glasgow Coma Sore (GCS) of 3/15. Patient was intu- bated immediately in view of low GCS and later was shifted to medicine ICU. Management of the patient was a difficult task as very less data and studies are available and there is unavailability of any specific antidote. However, confirmation of Amitraz poisoning is done after retrieval of container. Early clinical evaluation and detail history from both patient and informant is a key for successful management and ex- cellent outcome of treatment..
Full article
International Medical Journal
Journal ID : IMJ-29-10-2021-1028
Total View : 438

Abstract : Diabetes is associated with angiopathy and neuropathy. Both these issues can impact the inner ear and can result in hearing loss. Presbycusis contributes to hearing loss in elderly, however this effect may be more pronounced in diabetic patients. To compare hearing deficit in diabetics with non-diabetics. The study comprised of 30 diabetics and 30 nondiabetics who were age and sex matched. Informed consent was obtained prior to start of the study. Those with other co-morbid conditions impacting hearing capacity were excluded. Hearing profile was obtained, and mean hearing loss was compared between the 2 groups. There was significant difference between the 2 groups regarding hearing capacity. Diabetic patients had a more pronounced hearing loss when compared to nondiabetics and had higher number of bilateral hearing loss subjects. 60% of diabetics had some degree of hearing loss compared to 26.67% amongst nondiabetics. Diabetics should be screened for hearing as they are more prone to have hearing deficit..
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//